| Application no. and date | 97936295.1 (espacenet) (Federated) (European Patent Register), 19970724 | | Patent/reg. no. and date | DK/EP 0925294, 20021211 | | Publication date | 19990630 | | Priority no. and date | US 690258, 19960724, US 701494, 19960822, US 48278 P, 19970530 | | EP pub. no. and date |
EP 0925294 19990630 | | Effective date | | | Applicant/owner | CELGENE CORPORATION, 7 Powder Horn Drive
Warren, NJ 07059, US | | Applicant ref. no. | 21779DK00 | | Inventor | MULLER, George, W., 250 Windmill Court
Bridgewater, NJ 08807, US,
STIRLING, David, I., 3281 Round Hill Road
Branchburg, NJ 08876, US,
CHEN, Roger, Shen-Chu, 110 Christie Street
Edison, NJ 08820, US | | Representative | Inspicos P/S, Agern Alle 24 , 2970 Hørsholm | | Opponent | Celgene Corporation, 7 Powder Horn Drive
Warren
New Jersey 07059, US | | IPC Class | A61K 31/445 (2006.01) , C07D 401/04 (2006.01) | | Title | SUBSTITUEREDE 2-(2,6-DIOXOPIPERIDIN-3-YL)PHTHALIMIDER OG -1-OXOISOINDOLINER SAMT FREMGANGSMÅDE TIL REDUKTION AF TNF-ALPHA-NIVEAUER | | Int. application no. | US1997013375 | | Int. publication no. | WO1998003502 | | Related patent (certificate) | CA 2007 00054 | | Status | DK/EP patent med begrænsede krav | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
